Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Income Statement
Earnings Waterfall
Chongqing Zhifei Biological Products Co Ltd
Revenue
|
49.7B
CNY
|
Cost of Revenue
|
-35.2B
CNY
|
Gross Profit
|
14.5B
CNY
|
Operating Expenses
|
-4.6B
CNY
|
Operating Income
|
9.9B
CNY
|
Other Expenses
|
-1.4B
CNY
|
Net Income
|
8.5B
CNY
|
Income Statement
Chongqing Zhifei Biological Products Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
844
N/A
|
780
-8%
|
758
-3%
|
735
-3%
|
777
+6%
|
801
+3%
|
835
+4%
|
805
-4%
|
779
-3%
|
713
-8%
|
660
-7%
|
512
-22%
|
431
-16%
|
446
+4%
|
464
+4%
|
707
+52%
|
942
+33%
|
1 343
+43%
|
2 019
+50%
|
2 969
+47%
|
4 068
+37%
|
5 228
+29%
|
6 683
+28%
|
8 195
+23%
|
9 400
+15%
|
10 587
+13%
|
10 928
+3%
|
12 542
+15%
|
13 971
+11%
|
15 190
+9%
|
16 482
+9%
|
21 368
+30%
|
25 969
+22%
|
30 652
+18%
|
35 567
+16%
|
35 835
+1%
|
36 647
+2%
|
38 264
+4%
|
40 596
+6%
|
44 356
+9%
|
49 712
+12%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(368)
|
(340)
|
(291)
|
(274)
|
(291)
|
(320)
|
(328)
|
(283)
|
(223)
|
(146)
|
(77)
|
(49)
|
(35)
|
(58)
|
(41)
|
(63)
|
(119)
|
(319)
|
(671)
|
(1 118)
|
(1 726)
|
(2 378)
|
(3 401)
|
(4 525)
|
(5 355)
|
(6 154)
|
(6 468)
|
(7 534)
|
(8 378)
|
(9 316)
|
(10 005)
|
(10 557)
|
(12 797)
|
(15 714)
|
(19 323)
|
(22 502)
|
(24 335)
|
(25 504)
|
(27 509)
|
(30 607)
|
(35 203)
|
|
Gross Profit |
476
N/A
|
440
-7%
|
468
+6%
|
462
-1%
|
486
+5%
|
481
-1%
|
507
+5%
|
522
+3%
|
556
+6%
|
567
+2%
|
583
+3%
|
463
-21%
|
396
-15%
|
388
-2%
|
423
+9%
|
644
+52%
|
823
+28%
|
1 023
+24%
|
1 348
+32%
|
1 851
+37%
|
2 342
+27%
|
2 850
+22%
|
3 283
+15%
|
3 670
+12%
|
4 045
+10%
|
4 433
+10%
|
4 461
+1%
|
5 008
+12%
|
5 592
+12%
|
5 875
+5%
|
6 477
+10%
|
10 811
+67%
|
13 172
+22%
|
14 938
+13%
|
16 244
+9%
|
13 333
-18%
|
12 312
-8%
|
12 760
+4%
|
13 087
+3%
|
13 749
+5%
|
14 510
+6%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(270)
|
(317)
|
(344)
|
(343)
|
(354)
|
(333)
|
(355)
|
(362)
|
(388)
|
(376)
|
(377)
|
(384)
|
(379)
|
(377)
|
(410)
|
(439)
|
(475)
|
(523)
|
(597)
|
(733)
|
(866)
|
(1 128)
|
(1 229)
|
(1 342)
|
(1 446)
|
(1 556)
|
(1 540)
|
(1 671)
|
(1 846)
|
(1 855)
|
(1 962)
|
(2 174)
|
(2 252)
|
(2 928)
|
(3 081)
|
(3 373)
|
(3 662)
|
(4 009)
|
(4 175)
|
(4 411)
|
(4 633)
|
|
Selling, General & Administrative |
(264)
|
(272)
|
(302)
|
(297)
|
(309)
|
(280)
|
(341)
|
(353)
|
(376)
|
(298)
|
(362)
|
(359)
|
(350)
|
(283)
|
(368)
|
(397)
|
(437)
|
(416)
|
(569)
|
(714)
|
(799)
|
(952)
|
(1 006)
|
(1 119)
|
(1 239)
|
(1 362)
|
(1 398)
|
(1 445)
|
(1 539)
|
(1 525)
|
(1 630)
|
(1 838)
|
(1 977)
|
(2 386)
|
(2 503)
|
(2 629)
|
(2 740)
|
(3 134)
|
(3 139)
|
(3 395)
|
(3 717)
|
|
Research & Development |
0
|
(33)
|
0
|
0
|
0
|
(39)
|
0
|
0
|
0
|
(58)
|
0
|
0
|
0
|
(59)
|
0
|
0
|
(23)
|
(78)
|
0
|
0
|
(44)
|
(124)
|
(130)
|
(167)
|
(160)
|
(149)
|
(186)
|
(208)
|
(286)
|
(300)
|
(314)
|
(356)
|
(319)
|
(553)
|
(652)
|
(778)
|
(920)
|
(854)
|
(907)
|
(903)
|
(895)
|
|
Depreciation & Amortization |
0
|
(13)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(35)
|
0
|
0
|
0
|
(36)
|
0
|
0
|
0
|
(54)
|
0
|
0
|
0
|
(56)
|
0
|
0
|
0
|
(39)
|
0
|
0
|
0
|
(75)
|
0
|
0
|
0
|
(74)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(6)
|
0
|
(42)
|
(46)
|
(45)
|
0
|
(14)
|
(8)
|
(12)
|
0
|
(15)
|
(25)
|
(29)
|
0
|
(42)
|
(42)
|
(14)
|
7
|
(29)
|
(19)
|
(23)
|
2
|
(94)
|
(57)
|
(47)
|
12
|
45
|
(17)
|
(21)
|
9
|
(18)
|
20
|
44
|
86
|
74
|
34
|
(1)
|
53
|
(129)
|
(113)
|
(21)
|
|
Operating Income |
206
N/A
|
123
-40%
|
124
+1%
|
118
-5%
|
132
+12%
|
148
+12%
|
152
+2%
|
161
+6%
|
168
+4%
|
191
+14%
|
206
+8%
|
79
-61%
|
17
-78%
|
11
-36%
|
14
+23%
|
205
+1 415%
|
348
+70%
|
500
+44%
|
751
+50%
|
1 118
+49%
|
1 477
+32%
|
1 722
+17%
|
2 054
+19%
|
2 328
+13%
|
2 599
+12%
|
2 877
+11%
|
2 921
+2%
|
3 337
+14%
|
3 747
+12%
|
4 020
+7%
|
4 516
+12%
|
8 637
+91%
|
10 920
+26%
|
12 010
+10%
|
13 164
+10%
|
9 960
-24%
|
8 650
-13%
|
8 750
+1%
|
8 912
+2%
|
9 338
+5%
|
9 877
+6%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
29
|
28
|
27
|
25
|
25
|
24
|
24
|
23
|
28
|
28
|
29
|
27
|
22
|
18
|
16
|
15
|
11
|
12
|
9
|
4
|
(2)
|
(9)
|
(29)
|
(42)
|
(61)
|
(64)
|
(100)
|
(122)
|
(137)
|
(125)
|
(140)
|
(118)
|
(60)
|
(10)
|
(4)
|
11
|
(8)
|
8
|
(26)
|
(29)
|
(42)
|
|
Non-Reccuring Items |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
43
|
43
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
2
|
3
|
3
|
3
|
4
|
3
|
5
|
6
|
7
|
10
|
10
|
9
|
9
|
7
|
8
|
4
|
3
|
(8)
|
(20)
|
(19)
|
(28)
|
(17)
|
(53)
|
(52)
|
(52)
|
(46)
|
(27)
|
(27)
|
(20)
|
(40)
|
(34)
|
(50)
|
(73)
|
(66)
|
(67)
|
(65)
|
(54)
|
(40)
|
(39)
|
(25)
|
(23)
|
|
Pre-Tax Income |
237
N/A
|
153
-36%
|
155
+1%
|
146
-5%
|
161
+10%
|
175
+9%
|
181
+3%
|
189
+5%
|
202
+7%
|
231
+14%
|
244
+6%
|
116
-53%
|
48
-59%
|
36
-25%
|
37
+3%
|
224
+503%
|
363
+62%
|
505
+39%
|
739
+46%
|
1 103
+49%
|
1 447
+31%
|
1 692
+17%
|
1 972
+17%
|
2 234
+13%
|
2 486
+11%
|
2 765
+11%
|
2 794
+1%
|
3 189
+14%
|
3 590
+13%
|
3 854
+7%
|
4 342
+13%
|
8 469
+95%
|
10 787
+27%
|
11 931
+11%
|
13 093
+10%
|
9 906
-24%
|
8 588
-13%
|
8 718
+2%
|
8 847
+1%
|
9 327
+5%
|
9 855
+6%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(35)
|
(22)
|
(23)
|
(22)
|
(25)
|
(27)
|
(28)
|
(29)
|
(30)
|
(33)
|
(35)
|
(14)
|
(4)
|
(3)
|
(4)
|
(32)
|
(52)
|
(72)
|
(108)
|
(160)
|
(214)
|
(241)
|
(278)
|
(318)
|
(358)
|
(399)
|
(413)
|
(465)
|
(508)
|
(553)
|
(619)
|
(1 182)
|
(1 560)
|
(1 723)
|
(1 900)
|
(1 459)
|
(1 176)
|
(1 179)
|
(1 199)
|
(1 257)
|
(1 392)
|
|
Income from Continuing Operations |
203
|
130
|
132
|
124
|
136
|
148
|
153
|
160
|
172
|
197
|
209
|
101
|
44
|
33
|
34
|
192
|
311
|
432
|
632
|
943
|
1 234
|
1 451
|
1 694
|
1 916
|
2 128
|
2 366
|
2 381
|
2 724
|
3 082
|
3 301
|
3 723
|
7 287
|
9 226
|
10 209
|
11 193
|
8 447
|
7 412
|
7 539
|
7 648
|
8 070
|
8 462
|
|
Net Income (Common) |
203
N/A
|
130
-36%
|
132
+1%
|
124
-6%
|
136
+9%
|
148
+9%
|
153
+3%
|
160
+5%
|
172
+7%
|
197
+15%
|
209
+6%
|
101
-52%
|
44
-57%
|
33
-24%
|
34
+2%
|
192
+472%
|
311
+62%
|
432
+39%
|
632
+46%
|
943
+49%
|
1 234
+31%
|
1 451
+18%
|
1 694
+17%
|
1 916
+13%
|
2 128
+11%
|
2 366
+11%
|
2 381
+1%
|
2 724
+14%
|
3 082
+13%
|
3 301
+7%
|
3 723
+13%
|
7 287
+96%
|
9 226
+27%
|
10 209
+11%
|
11 193
+10%
|
8 447
-25%
|
7 412
-12%
|
7 539
+2%
|
7 648
+1%
|
8 070
+6%
|
8 462
+5%
|
|
EPS (Diluted) |
0.13
N/A
|
0.08
-38%
|
0.09
+13%
|
0.15
+67%
|
0.08
-47%
|
0.09
+13%
|
0.09
N/A
|
0.11
+22%
|
0.11
N/A
|
0.12
+9%
|
0.13
+8%
|
0.06
-54%
|
0.03
-50%
|
0.02
-33%
|
0.03
+50%
|
0.13
+333%
|
0.2
+54%
|
0.27
+35%
|
0.39
+44%
|
0.58
+49%
|
0.76
+31%
|
0.91
+20%
|
1.05
+15%
|
1.19
+13%
|
1.33
+12%
|
1.48
+11%
|
1.49
+1%
|
1.71
+15%
|
1.93
+13%
|
2.06
+7%
|
2.33
+13%
|
4.56
+96%
|
5.77
+27%
|
4.25
-26%
|
7
+65%
|
5.28
-25%
|
3.08
-42%
|
3.14
+2%
|
3.18
+1%
|
3.36
+6%
|
3.53
+5%
|